Longitudinal describes a position parallel to the long axis of the body.

(LCD) The low contrast detectability represents the ability of a CT scanner to distinguish between objects that have similar x-ray attenuation coefficients. In cases of other diagnostic imaging modalities it means the ability of imaging equipment to differentiate between objects that have similar properties.

(LCR) The low contrast resolution describes the ability to discriminate between tissues with slightly differences in attenuation properties. The LCR depends on the stochastic noise.
The low contrast resolution is usually expressed as the minimum detectable size of an image structure, for a fixed percentage difference in contrast relative to the adjacent background.
A strength of computed tomography (CT) is its ability to visualize structures of low contrast in an object, a task that is limited by noise and is closely associated with the radiation dose. For example, a reduction of the dose at constant spatial resolution affects the visibility of structures with low contrast (e.g. vessels in the liver), due to increased noise. The visibility of these low contrast structures can partly be improved by decreasing the spatial resolution, while keeping the dose constant.

See also CT Number, Image Quality and Low Contrast Detectability.

(LDR) The low dose rate is used in brachytherapy to estimate the use of sealed sources placed in a patient on a permanent or temporary basis to achieve the therapeutic dose of radiation.

(LOCM) Low-osmolar contrast media have a wide range of indications due to their lower side effects. The type of contrast media is an important risk factor for an adverse reaction.
LOCM have not completely replaced contrast media with higher osmolality due to their higher cost. Guidelines of professional organizations give recommendations for the selective use of low-osmolar contrast media for certain high-risk patients.
There are ionic and nonionic iodinated contrast materials with low osmolality available:
An adverse reaction occurs in low-risk patients who receive conventional ionic contrast agents more often than in high-risk patients who receive nonionic LOCM.

See also Contrast Enhancement, Biliary Contrast Agents, Safety of Contrast Agents and Contrast-Induced Nephropathy.